Using genomic alterations to predict relapse following immunotherapy in multiple myeloma
Francesco Maura, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, discusses a study investigating the role of genomic alterations in relapse following immunotherapy in multiple myeloma. The findings can help predict patient response to treatment, assisting in the selection of optimal therapeutic approaches. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.